Recruiting
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
NCT05923905
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China